Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4554128
Max Phase: Preclinical
Molecular Formula: C51H89N3O15
Molecular Weight: 984.28
Molecule Type: Unknown
Associated Items:
ID: ALA4554128
Max Phase: Preclinical
Molecular Formula: C51H89N3O15
Molecular Weight: 984.28
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCCC(=O)N(C(C)C)C(C[C@H]1C[C@@H](C)C(=O)/C=C/C(C)=C/[C@H](CO[C@H]2O[C@@H](C)[C@H](O)[C@H](OC)[C@@H]2OC)[C@@H](CC)OC(=O)C[C@@H](O)[C@H](C)[C@H]1O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N(C)C)[C@H]1O)C(=O)NC(C)(C)C
Standard InChI: InChI=1S/C51H89N3O15/c1-17-19-39(57)54(27(3)4)35(48(62)52-51(10,11)12)24-33-23-29(6)36(55)21-20-28(5)22-34(26-65-50-47(64-16)46(63-15)43(60)32(9)67-50)38(18-2)68-40(58)25-37(56)30(7)45(33)69-49-44(61)41(53(13)14)42(59)31(8)66-49/h20-22,27,29-35,37-38,41-47,49-50,56,59-61H,17-19,23-26H2,1-16H3,(H,52,62)/b21-20+,28-22+/t29-,30+,31-,32+,33-,34-,35?,37-,38-,41+,42-,43+,44-,45-,46+,47+,49+,50+/m1/s1
Standard InChI Key: HFHUHTOLUDTVTA-OVCFEIRGSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 984.28 | Molecular Weight (Monoisotopic): 983.6294 | AlogP: 3.68 | #Rotatable Bonds: 16 |
Polar Surface Area: 232.32 | Molecular Species: NEUTRAL | HBA: 16 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 18 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 12.54 | CX Basic pKa: 7.94 | CX LogP: 3.92 | CX LogD: 3.27 |
Aromatic Rings: 0 | Heavy Atoms: 69 | QED Weighted: 0.14 | Np Likeness Score: 1.07 |
1. Budragchaa T, Westermann B, Wessjohann LA.. (2019) Multicomponent synthesis of α-acylamino and α-acyloxy amide derivatives of desmycosin and their activity against gram-negative bacteria., 27 (15): [PMID:31229422] [10.1016/j.bmc.2019.05.046] |
Source(1):